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ABSTRACT
Background
Epidemiological studies may be subject to selective reporting, but empirical evidence thereof
is limited. We empirically evaluated the extent of selection of significant results and large effect
sizes in a large sample of recent articles.
Methods and Findings
We evaluated 389 articles of epidemiological studies that reported, in their respective
abstracts, at least one relative risk for a continuous risk factor in contrasts based on median,
tertile, quartile, or quintile categorizations. We examined the proportion and correlates of
reporting statistically significant and nonsignificant results in the abstract and whether the
magnitude of the relative risks presented (coined to be consistently  1.00) differs depending
on the type of contrast used for the risk factor. In 342 articles (87.9%),  1 statistically significant
relative risk was reported in the abstract, while only 169 articles (43.4%) reported  1
statistically nonsignificant relative risk in the abstract. Reporting of statistically significant
results was more common with structured abstracts, and was less common in US-based studies
and in cancer outcomes. Among 50 randomly selected articles in which the full text was
examined, a median of nine (interquartile range 5–16) statistically significant and six
(interquartile range 3–16) statistically nonsignificant relative risks were presented (p ¼ 0.25).
Paradoxically, the smallest presented relative risks were based on the contrasts of extreme
quintiles; on average, the relative risk magnitude was 1.41-, 1.42-, and 1.36-fold larger in
contrasts of extreme quartiles, extreme tertiles, and above-versus-below median values,
respectively (p , 0.001).
Conclusions
Published epidemiological investigations almost universally highlight significant associations
between risk factors and outcomes. For continuous risk factors, investigators selectively present
contrasts between more extreme groups, when relative risks are inherently lower.
The Editors’ Summary of this article follows the references.
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PLoS MEDICINEIntroduction
Researchers sometimes selectively present their ﬁndings,
focusing on the more impressive aspects of their work.
Focusing on impressive aspects means that researchers may
try to show statistically signiﬁcant results and/or larger effect
sizes. Testing for statistical signiﬁcance is not necessarily a
bad thing, even though the process has been criticized [1]. In
theory, it can help keep chance ﬁndings out of the literature.
However, problems ensue when signiﬁcance testing is
accompanied by selective reporting, and we do not know
how many hypotheses have been examined and in how many
different ways the data have been analyzed. Some studies with
statistically nonsigniﬁcant (‘‘negative’’) results may remain
unpublished (publication bias) [2–4] or may be published with
delay compared with statistically signiﬁcant (‘‘positive’’)
studies (time-lag bias) [5,6]. Bias may also affect the reporting
of results within studies: ‘‘positive’’ outcomes may be
reported preferentially over potentially less appealing ‘‘neg-
ative’’ analyses, even if this distorts the original analysis plan
[7,8]. Emphasis may be given to post-hoc subgroup analyses
[9] or to dubious adjustments [10,11] that claim statistical
signiﬁcance [11].
While these biases have been studied predominantly in the
randomized trials literature, selective reporting may be more
prominent in epidemiological research [4]. Moreover, report-
ing of epidemiological results lacks standardization [12,13].
Thus, there is plenty of room for selective reporting. This is
difﬁcult to prove without access to the original protocols of
these studies while, sometimes, protocols may not even exist.
Refutations of epidemiological associations [14–17] pose the
question as to whether biased ﬁndings are common. One may
obtain some indirect evidence by examining the presented
results of epidemiological studies. If most presented results
are ‘‘positive’’ and few are ‘‘negative,’’ this may offer indirect
evidence for selective reporting.
Moreover, one may examine how epidemiological estimates
of risk are presented in the literature. Is there a preference to
show larger magnitudes of effect? For risk factors that take
continuous values, the presented magnitude of the relative
risk may depend on the selected contrast. The risk may be
presented per unit change, per standard deviation, or
according to a contrast of speciﬁc percentile groups of the
values of the postulated risk factor. The latter option is very
popular. Typical contrasts involve splitting the data into
quintiles, quartiles, tertiles, and above-versus-below the
median value of the risk factor. Unless a risk relationship is
J- or U-shaped, when the compared groups are further apart,
the estimated relative risk would deviate further from the
‘‘null’’ value of 1.00. For example, if consumption of a
nutrient is associated with the risk of prostate cancer, then
the risk ratio may be 1.10 when values of above-versus-below
the median are compared, but in the same data, the risk ratio
may be 1.50 if extreme quintiles are compared. When relative
risks are inherently more modest, do investigators select to
compare groups that are further apart?
Here we examined empirically a sample of published
articles on epidemiological studies that presented relative
risk estimates for continuous risk factors with percentile-
based contrasts. The analysis had two objectives. First, we
aimed to estimate how many articles highlight ‘‘positive’’ or
‘‘negative’’ results and to identify correlates thereof. Second,
it was our intention to identify whether the magnitude of the
highlighted risk was related to the selected percentile
contrast for the risk factor.
Methods
Eligible Studies and Search Strategy
We assembled a systematic sample of recent epidemiolog-
ical articles that presented, in their respective abstracts, at
least one relative risk for at least one continuous risk factor in
contrasts based on median, tertile, quartile, or quintile
categorizations. The following seven contrasts were consid-
ered eligible: above-versus-below median values; extreme
tertiles; extreme tertile versus remaining subjects; extreme
quartiles; extreme quartile versus remaining subjects; ex-
treme quintiles; and extreme quintile versus remaining
subjects. A pilot literature screen suggested that other
percentile-based categorizations are uncommon. Contrasts
between two extreme groups were considered eligible,
regardless of whether estimates were also presented for
contrasts between one extreme and one intermediate group.
For example, the extreme quartiles category considers all
studies in which a relative risk for the contrast of extreme
quartiles is presented, regardless of whether data are
presented for the contrast of the third versus ﬁrst quartile
and the second versus ﬁrst quartile. Whenever the contrast
was not clear from the abstract, we searched the full article.
We did not consider slope estimates, i.e., a change in odds
ratio for each unit change in exposure, since this does not
require any choice for categorization of exposure levels.
We accepted all multiplicative-effect metrics as measures of
relative risk, including hazard ratios, incidence rate ratios,
risk ratios, and odds ratios. We did not consider studies where
a continuous outcome, rather than the postulated risk factor,
was categorized according to some percentile grouping. We
considered epidemiological studies regardless of their design,
but excluded meta-analyses, as we focused on primary studies.
We used a search strategy that would favor the selection of
cohort studies. Cohort studies are traditionally the most
deﬁnitive type of epidemiological investigation. However,
they are less common in the literature than case-control and
cross-sectional designs. To enrich our sample with cohort
designs, we searched PubMed (http://www.ncbi.nlm.nih.gov/
entrez/query.fcgi?DB¼pubmed), combining the term cohort*
with quintile*, quartile*, tertile*, or (median AND [above OR
below]) as words in the abstract. Only English-language
articles were considered. We included all eligible retrieved
articles published in a period starting 1 January 2004 and
indexed until the last search update (28 October 2005).
Data Extraction
For each article that reported, in the abstract, at least one
numerical relative risk estimate for any of the seven eligible
percentile-based contrasts, we recorded the ﬁrst author,
journal of publication, impact factor of the journal (accord-
ing to Journal Citation Reports [18]), ﬁrst country listed in the
PubMed record, cohort of origin, presence of any structure
(section headings) in the abstract, and design. Design was
broadly categorized as cohort design, reporting any metric
other than odds ratio (e.g., hazard ratio or incidence rate
ratio); case-control design, reporting odds ratio; and other
cohorts of subjects with reported odds ratios (including cross-
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but without clearly deﬁned cases and controls). We also
recorded whether any statistically signiﬁcant relative risk (for
any continuous or discrete risk factor and for any type of
contrast) was reported numerically in the abstract. Similarly,
we recorded whether any statistically nonsigniﬁcant relative
risk was reported numerically in the abstract. Statistical
signiﬁcance was inferred from p-values (0.05 threshold) or
95% conﬁdence intervals (CIs).
We also extracted detailed data for one eligible relative risk
per study. Epidemiological studies often test numerous
hypotheses and estimate numerous relative risks. Investiga-
tors may mention in the abstract what they consider to be the
key ﬁndings of their work. To avoid subjective selection on
our part, we always chose the ﬁrst eligible relative risk
presented numerically in the abstract. The choice of the ﬁrst
presented relative risk has been adopted also in previous
empirical research on epidemiological studies [12]. For this
relative risk, we noted the type of contrast, point estimate,
95% CI, whether or not it was formally statistically signiﬁcant,
tested risk factor, and outcome/endpoint assessed.
Risk factors were categorized as dietary intake and dietary
patterns; toxic exposures and markers thereof; biological
markers in any biological ﬂuid or tissue; psychological,
behavioral, or social factors; physical activity or energy
expenditure; body characteristics and composition; and
other. Outcomes were classiﬁed as mortality versus non-
mortality; the latter were further classiﬁed into malignancies,
vascular (including cardiac, cerebrovascular, and other
vascular), and other.
We did not record the sample size of each study, because
the pertinent sample for each presented relative risk might
differ from the overall sample. Instead, we calculated the
standard error of the natural logarithm of the relative risk.
The standard error is given by the absolute value of the
difference between upper and lower 95% CI divided by 3.92.
The inverse of the standard error is a more appropriate
measure of precision than plain sample size.
Abstracts may be biased towards reporting the most
signiﬁcant results, but such selection may not affect the
information available in the full text. Moreover, another issue
concerns whether the predominance of signiﬁcant results in
the abstract might be less prominent if all presented relative
risks were examined rather than the ﬁrst one alone. There-
fore, for sensitivity analyses, we also evaluated 50 randomly
selected articles in more depth, where we recorded all the
respective relative risks presented in both the abstract and in
the full text.
All data were extracted in duplicate by two independent
investigators. Discrepancies were resolved by consensus.
Analyses
We evaluated the proportion of studies that had at least
one statistically signiﬁcant relative risk estimate presented
numerically in the abstract. We examined whether this was
related to any of the study characteristics mentioned above.
We ﬁrst performed univariate logistic regressions. In multi-
variate models, a variable was considered initially only if it
had p , 0.25 in the univariate analysis; we then used
backward elimination using likelihood ratio criteria with a p
¼ 0.05 threshold. All analyses that we performed for all
variables considered are shown in tabulated form for the
odds ratios derived from the regression coefﬁcients and their
95% CIs. No varying forms models or complex interaction
terms were evaluated. Similarly, we examined whether there
was any relationship between these speciﬁc variables and the
reporting of at least one statistically nonsigniﬁcant relative
risk.
In sensitivity analyses using full texts (50 articles), we used
Wilcoxon rank sum tests to examine whether the number of
signiﬁcant relative risks presented in the abstract and in the
full text of results exceeded the nonsigniﬁcant ones. We
tested (using McNemar and Wilcoxon signed rank tests)
whether the proportion of signiﬁcant relative risks and the
magnitude of the relative risks were different, and when the
ﬁrst eligible relative risk presented in the text was selected,
rather than the time of selecting the ﬁrst eligible relative risk
presented in the abstract.
Analyses of the magnitude of the presented relative risks
used only the ﬁrst eligible relative risk per study presented in
the abstract. We coined all relative risk estimates in such a
way that they would be  1.00; i.e., relative risks ,1.00 were
inverted so as to focus consistently on the extent of deviation
from the ‘‘null.’’ Values were log-transformed. Analysis of
variance (ANOVA) compared ﬁrst the four contrasts of two
extreme groups (extreme quintiles, extreme quartiles, ex-
treme tertiles, and above-versus-below median values). Then,
we considered both types of contrasts (comparison of the two
extreme groups or comparison of one extreme group versus
all the remaining subjects) and type of percentile; the above-
versus-below median contrast was not relevant in this
analysis.
Finally, we examined with ANOVA whether the choice of
contrast was related to the degree to which a study was well
powered, i.e., whether studies chose contrasts comparing
more extreme groups, and when they had more sufﬁcient
power (lower standard errors of the relative risk estimates).
Analyses were conducted in SPSS 13.0 (http://www.spss.
com). p-Values are two-tailed.
Results
Eligible Studies
The electronic search yielded 850 articles; 461 were
rejected upon screening (Figure 1) and 389 articles were
eligible (Tables 1 and S1). Epidemiology and nutrition
journals were common venues of publication for these
studies, but many specialty clinical journals also published
such studies, and 28 articles appeared in major general
journals (Annals of Internal Medicine [n ¼ 5], Archives of Internal
Medicine [n ¼ 12], CMAJ: Canadian Medical Association Journal
(Journal de l’Association Medicale Canadienne) [n ¼ 1], JAMA: The
Journal of the American Medical Association [n ¼ 7], and New
England Journal of Medicine [n ¼ 3], although none appeared in
Lancet or BMJ). Almost a quarter of the 389 studies appeared
in journals that have an impact factor of above seven. Half of
the 389 studies originated from the United States. Twenty-
four cohorts contributed more than one article (totaling 152
articles, 39.1%) to the eligible 389 articles. In particular, 54
articles (13.9%) originated from the large cohorts established
at Harvard University (i.e., Nurses’ Health Study/Physicians’
Health Study/Health Professionals’ Follow-up Study), fol-
lowed by ARIC (Atherosclerosis Risk in Community, n ¼ 11)
and EPIC (European Prospective Investigation into Cancer
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as intended. Structured abstracts were very common. The
comparison of extreme quartiles was the most frequent type
of contrast among the ﬁrst presented relative risks. Contrasts
of extreme tertiles and extreme quintiles were also common.
Contrasts of one extreme group against the remaining
subjects were far less frequent.
First Reported Relative Risks
The median was 1.73 (interquartile range [IQR] 1.39–2.48)
when all relative risks were coined to be  1.00, and only 22 of
these relative risks (5.7%) exceeded 5.0. Four-ﬁfths of these
relative risks were statistically signiﬁcant (Table 2). Among
risk factors, biological markers and dietary factors accounted
together for more than two-thirds of the studies. Non-
mortality outcomes were involved in the vast majority of
studies (Table 2).
Correlates of Significant and Nonsignificant Relative Risks
Almost nine out of ten articles (342/389; 87.9%) reported
 1 statistically signiﬁcant relative risk in the abstract. The
proportion of abstracts with  1 statistically nonsigniﬁcant
relative risk was only 169/389 (43.4%). Among 30 excluded
articles where otherwise eligible relative risks appeared, but
without exact numerical information, proportions were
93.3% and 56.7%, respectively.
Reporting at least one statistically signiﬁcant risk in the
abstract was positively related to the presence of a structured
abstract, and it was less likely in studies originating from the
United States and in studies of cancer outcomes in both
univariate and multivariate analyses (Table 3). Conversely,
reporting at least one nonsigniﬁcant relative risk in the
abstract was more likely in studies originating from the
United States and in studies of cancer outcomes. Moreover,
the reporting of ‘‘negative’’ results was also related to the type
of risk factor: studies on psychosocial risk factors or body
composition and characteristics were even less likely to
report any statistically nonsigniﬁcant risk (Table 3).
Evaluation of Full Texts
In the 50 randomly selected articles evaluated in depth, the
abstracts had a median of two statistically signiﬁcant relative
risks (IQR 1–3) versus zero nonsigniﬁcant risks (IQR 0–1). A
preponderance of statistically signiﬁcant relative risks was
seen in 33 articles (66%), a preponderance of nonsigniﬁcant
risks was noted in ﬁve articles (10%), and equal numbers were
seen in 12 articles (24%) (Wilcoxon, p , 0.001).
In the full text, the median number of articles reporting
any statistically signiﬁcant relative risk was nine (IQR 5–16)
versus six articles reporting nonsigniﬁcant risks (IQR 3–16).
In 28 articles (56%), more statistically signiﬁcant relative risks
were reported than statistically nonsigniﬁcant relative risks.
Figure 1. Flow Diagram for Studies Included or Excluded from the
Analyses According to Eligibility Criteria
doi:10.1371/journal.pmed.0040079.g001
Table 1. Characteristics of Analyzed Studies
Characteristic Journal or Category Articles
(n [%])
Most frequent journals Cancer Epidemiology, Biomarkers,
and Prevention
29 (7.5)
American Journal of Clinical Nutrition 23 (5.9)
American Journal of Epidemiology 21 (5.4)
International Journal of Cancer. Journal
International du Cancer
17 (4.4)
Diabetes Care 16 (4.1)
Journal of the National Cancer Institute 12 (3.1)
Archives of Internal Medicine 12 (3.1)
Stroke 12 (3.1)
Circulation 10 (2.6)
Neurology 9 (2.3)
Impact factor . 7 90 (23.1)
US affiliation 199 (51.2)
More than one publication
from same cohort
a
152 (39.1)
Structured abstract 268 (68.9)
Design and metric Case-control, OR 72 (18.5)
Other, OR 82 (21.1)
Cohort, other than OR 235 (60.4)
Any significant relative risk 342 (87.9)
Any nonsignificant relative risk 169 (43.4)
First presented percentile
contrasts
b
Median 11 (2.8)
Extreme tertiles 75 (19.3)
Extreme quartiles 167 (42.9)
Extreme quintiles 110 (28.3)
Extreme tertile versus other 7 (1.8)
Extreme quartile versus other 16 (4.1)
Extreme quintile versus other 3 (0.8)
n ¼ 389.
OR, odds ratio.
aArticles that originated from cohorts which contributed at least two articles in the
sample of 389 articles.
bThe categorization does not separate contrasts of high versus low values from contrasts
of low versus high values for the postulated risk factor; for example, contrasts of the top
versus bottom quartile and of the bottom versus top quartile are grouped in the same
category. Contrasts of extreme groups are categorized together regardless of whether
contrasts involving intermediate groups are also listed in the abstract; for example, the
‘‘extreme quartile’’ category includes all studies in which a relative risk of extreme
quartiles is presented, regardless of whether or not data are also presented for the
contrast of the third versus first quartile and second versus first quartile.
doi:10.1371/journal.pmed.0040079.t001
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risks than signiﬁcant ones, and in two articles (4%) there was
an equal number of signiﬁcant and nonsigniﬁcant relative
risks (Wilcoxon, p ¼ 0.25). None of the 50 articles reported
only a single relative risk. Only four out of the 50 articles
claimed to be the ﬁrst study assessing a speciﬁc association,
while a further ﬁve articles claimed to be the ﬁrst to address a
previously tested association in a new setting (based on
population characteristics or type of study design).
The ﬁrst reported relative risk with eligible contrast in the
full text was formally statistically signiﬁcant in 35 articles
(70%). The median relative risk was 1.54 (IQR 1.30–2.43),
when relative risks were consistently coined to be  1. These
values are similar to the respective values for the ﬁrst
reported relative risk with eligible contrast in the abstract
(McNemar, p ¼ 0.15 for signiﬁcant results; Wilcoxon, p ¼ 0.12
for median coined relative risk).
In three articles, the ﬁrst reported relative risk was not
formally signiﬁcant, but the authors nevertheless interpreted
this as an association. The inverse interpretation (i.e.,
formally signiﬁcant risk interpreted as nonsigniﬁcant by the
authors) was not seen in any of these 50 articles.
Magnitude of Risk for Different Contrasts
Figure 2 shows the distribution of relative risks (coined to
be  1.00) according to the type of contrast used to present
the postulated risk. Contrary to what would be expected, the
presented effects were smaller, on average, when the
compared groups of the postulated risk factor were further
apart. The smallest effects were described with the contrast of
extreme quintiles. Compared with the contrasts of extreme
quintiles, the relative risks were signiﬁcantly larger in
contrasts of extreme quartiles (1.41-fold larger), extreme
tertiles (1.42-fold larger), and above-versus-below median
(1.36-fold larger) (ANOVA, p , 0.001).
Moreover, the presented effects were smaller, on average,
when extreme groups were compared than when one extreme
group was compared against the remaining subjects (Figure
2). The relative risks were 0.81-fold lower (p ¼ 0.044) for
comparisons of the two extreme groups versus comparisons
of one extreme group against the remaining subjects after
adjusting for type of percentile involved in the contrast (1.37-
fold, and 1.36-fold larger relative risks with tertile contrasts
and quartile contrasts, respectively, compared with quintile
contrasts, p , 0.001). Only six studies referred explicitly to a
J- or U-shaped or nonlinear effect. Exclusion of these studies
did not change our results (unpublished data).
Study Precision for Different Contrasts
Compared with contrasts of above-versus-below the me-
dian, the standard error of the relative risks was similar, on
average, in studies with contrasts of extreme tertiles (on
average 1% larger) or extreme quartiles (on average 8%
smaller). The standard error was 49% lower on average when
extreme quintiles were contrasted (ANOVA, p , 0.001). Thus,
precision was maximal when the compared extreme groups
pertained to the smallest possible portion (extreme quintiles,
40%) of the study population.
Discussion
Epidemiological investigations almost universally highlight
signiﬁcant associations between risk factors and outcomes.
The vast majority of the 389 articles that we analyzed
reported some signiﬁcant results. Less than half of these
articles presented at least one nonsigniﬁcant relative risk in
their respective abstracts. This pattern suggests that there is a
strong predilection for highlighting ‘‘positive’’ results and
avoiding ‘‘negative’’ results. The preponderance of signiﬁcant
ﬁndings was less prominent in the full texts of these articles.
However, even in the full texts, an article reported, on
average, at least as many signiﬁcant relative risks as non-
signiﬁcant ones, and sometimes reported a greater number.
Despite some variability depending on country, tested risk
factor, and outcome, most important ﬁelds of epidemiolog-
ical investigation seem to have little room for ‘‘negative’’
ﬁndings.
Given the largely exploratory nature of most epidemio-
logical analyses, one would expect that most hypotheses
analyzed should be ‘‘negative.’’ A counter argument, however,
is that epidemiologists do not select null hypotheses at
random, but rather because there is some reason to believe
they are false. For most of the reported relative risks
considered in the present paper, there were already pertinent
results available, perhaps needing replication and reﬁnement.
However, even when studies were not the ﬁrst to report on a
tested hypothesis, there is no guarantee that previous studies
had found ‘‘positive’’ results, and the fact that a hypothesis is
tested repeatedly does not guarantee its credibility [19,20].
The exact expected proportion of statistically signiﬁcant
associations in the entire ﬁeld of epidemiological research is,
by default, unknown. However, we can gain some insights into
epidemiological research by examining the rate of replication
of epidemiological ﬁndings, each time similar hypotheses are
tested, using very large, well-conducted studies, preferably
with the most robust designs, such as randomized trials.
Empirical evidence shows than even among the most cited,
Table 2. Analyzed Eligible Relative Risks
Characteristic Category Subcategory Median
(IQR) or
n (%)
First relative risk (coined
 1.00), median (IQR)
1.73 (1.39–2.48)
Standard error, median
(IQR)
a
0.22 (0.15–0.33)
Significant first relative
risk (%)
307 (78.9)
Tested risk factor (%) Dietary 122 (31.4)
Toxic exposures 12 (3.1)
Biological markers 154 (39.6)
Psychosocial 31 (8.0)
Physical activity 8 (2.1)
Body composition 25 (6.4)
Other 37 (9.5)
Tested outcomes (%) Mortality 45 (12.1)
Non-mortality Malignancies 109 (28.0)
Vascular 92 (23.7)
Other 142 (36.5)
n ¼ 389 studies
aBased on data from 349 articles where standard error could be imputed from the point
estimate and CIs.
doi:10.1371/journal.pmed.0040079.t002
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Selection in Epidemiological Risksconﬁrmatory epidemiological studies, ﬁve out of six studies
have been refuted or were found to be exaggerated within a
few years of their publication in major journals [14]. In
modern epidemiology, we also have evidence that most
proposed associations are rejected when large-scale evidence
accumulates. For example, of 32 candidate gene associations
that proposed that common gene variants were associated
with breast cancer, large-scale evidence eventually indicated
that none remained formally signiﬁcant after correcting for
32 comparisons, and only a few associations maintained an
uncorrected p-value of less than 0.05 [21,22]. Another
argument comes from the sheer number of available
epidemiological factors under study. For example, we can
currently test millions of genetic variants and a vast number
of exposures. Even considering only independent variants
and independent exposures, the claimed associations already
could explain several-fold more than 100% of the attribut-
able fraction for each outcome. This was already an issue
almost three decades ago when Doll and Peto tried to
estimate attributable fractions for cancer risk factors [23],
and the scale of the problem has escalated in modern
epidemiology.
Our results extend the observation of a previous survey in
which 63 of 73 epidemiological studies in leading journals
had statistically signiﬁcant results [12]. Three quarters of the
analyzed risk relationships reﬂected effect sizes where the
compared groups differ less than 2.5-fold in their risk for the
outcome of interest. Relative risks exceeding ﬁve were very
rare. On the whole, the current literature presents modest
associations, and half of them cluster in the relatively narrow
relative risk range of 1.4–2.5. For some ﬁelds, the typical
relative risks may be even lower. The strength of an observed
epidemiological association is one of the classic criteria for
causality.
We observed a lower frequency of signiﬁcant results and a
higher frequency of nonsigniﬁcant results in US studies. It has
been previously reported [24] that studies from non-English
speaking countries may report signiﬁcant results more
frequently in the English literature. Nonsigniﬁcant results
may be reserved for the local non-English literature that is
typically not indexed in PubMed. However, the direction of
‘‘language bias’’ may vary across different ﬁelds [25,26]. In our
sample, relatively few articles were from English-speaking
countries other than the United States. The association of
presented signiﬁcant results with structured abstracts may
reﬂect the possibility that structured abstracts may encourage
the use of exact numbers. Finally, the association of fewer
signiﬁcant results with cancer outcomes may reﬂect a larger
prevalence of ‘‘negative’’ ﬁndings in cancer epidemiology
compared with other ﬁelds, such as cardiovascular disease.
Alternatively, it could be speculated whether there are more
journals specializing in cancer epidemiology.
Furthermore, we noted that when the compared groups
were further apart in the distribution of the values of the risk
factor, the presented relative risks were lower. The contrast
of extreme quintiles, the most extreme contrast of those
evaluated here, was used to present what were, on average,
the smallest relative risks. Investigators presented more
extreme contrasts when the risks were inherently lower. In
fact, studies with extreme contrasts apparently had been
designed upfront to have more power to detect small effects
than studies that reported more proximal contrasts. It could
be argued that there is nothing wrong with epidemiologists
designing contrasts that are more likely to reveal the
relationship that is being sought, provided the contrasts are
transparently reported. However, most non-methodologist
readers may still be misled. For example, by comparing the
extreme quintiles, a relative risk of 1.5 may be calculated,
while a contrast of people with above-versus-below median
values might have given a relative risk of 1.2, or even 1.1, for
Figure 2. Box Plots for Relative Risks for Different Contrasts of the Values of the Postulated Risk Factor
All relative risks have been coined to be  1.00 for consistency.
doi:10.1371/journal.pmed.0040079.g002
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Selection in Epidemiological Risksthe same dataset. The non-methodologist reader or the
general public would then be informed about a 50% relative
increase in the disease risk, rather than 20% or 10%—a more
impressive result that nevertheless pertains to the fewer
people of the extreme groups. Most readers and even
physicians may not understand that, with extreme groups
being compared, the presented risk pertains to only a
minority of people in the population. The use of relative
risk metrics, rather than measures of absolute risk, may cause
further misinterpretations and has been characterized as a
main source of confusion in understanding medical statistics
[27–29]. The problem is heightened when relative risks seem
even larger, because many apparently sizeable relative risks
eventually translate to negligible absolute risks [28,29].
We should also acknowledge that researchers and editors
may try to select and present what they deem to be the most
interesting and important work. The window on the world
offered by the published scientiﬁc literature is not compre-
hensive, but instead is a particular view reﬂecting a host of
complicated desires, abilities, and interests of the scientiﬁc
community. Whether statistical signiﬁcance should be one of
the criteria used to select work for presentation has been a
point of endless debate. However, at a minimum, if data are
selected based on signiﬁcance thresholds, it is important to
know the underlying multiplicity of the conducted analyses. A
signiﬁcant risk (for example, p , 0.05) that arises out of a
single hypothesis and a single analysis is very different than
one that arose out of a massive screening of potential risk
factors where it is not shown that many other risk factors
have also been screened.
Some additional limitations should be discussed. First, we
focused on articles that used speciﬁc percentile group
contrasts; this was dictated by our aim to investigate speciﬁc
selection biases based on these contrasts. We encourage
assessments of other designs (e.g., binary risk factors and non-
percentile contrasts); preliminary evidence suggests that the
pursuit of statistical signiﬁcance exists across all epidemio-
logical studies [12]. Second, no data existed with which to
compare presented relative risks with different types of
percentile contrasts in the same study because, with very rare
exceptions, each study used only one type of contrast.
Selection in primary studies could also affect the ﬁndings
and inferences of secondary analyses, leading to spurious
conclusions being drawn. A meta-analysis may ameliorate this
defect by using the raw (individual level) data without taking
into consideration the selected contrasts that had been
presented in each paper. However, this would require full
access to all data, and this is currently the exception.
Selection of outcomes and contrasts in the primary studies
may lead to similar selective choices in meta-analyses that
have to depend on published data. This would further
perpetuate these biases. Meta-analyses may try to detect and
address these selective reporting problems using a variety of
diagnostic tools such as asymmetry tests. However, having an
unbiased body of evidence is certainly preferable to trying to
detect and eliminate bias after the fact.
Our empirical ﬁndings may lead to some recommendations
on how to improve the situation. Epidemiological research is
very important [30], but reporting of epidemiological studies
needs standardization [12,13,31–33], as has been proposed for
clinical trials and other study designs [34–36]. The ‘‘STrength-
ening the Reporting of OBservational studies in Epidemiol-
ogy’’ (STROBE) statement and similar efforts in genetic
epidemiology are working in this direction. Investigators
should avoid the selective presentation, and dissemination, of
high-risk estimates and signiﬁcant results. They should give a
clear explanation of the way in which quantitative exposures
are analyzed e.g., which groupings are chosen, whether a
continuous analysis is done, and the rationale behind the
choice (continuous, trend test, or comparison to a reference
group) [37]. In particular, they should avoid estimating results
with various categorical contrasts and selecting what to
report simply based on the seemingly largest magnitude of
effect. Readers should also be advised to interpret cautiously
apparently large effects that are based on extreme contrasts
and should instead place them properly in the population
context. Study reports should also convey the exact breadth
of analyses that have been performed. While it may not be
possible to provide all ‘‘negative’’ results in detail, the reader
should be aware of the existence of these analyses that have
led to ‘‘negative’’ results. This is fairly challenging because, in
contrast with randomized trials [38], upfront registration of
epidemiological protocols may be very difﬁcult or unrealistic.
Some epidemiological research will unavoidably remain
exploratory and post hoc in nature. Even so, this exploratory
nature would need to be clariﬁed, and selective reporting
minimized, so that epidemiological ﬁndings could be inter-
preted in the most appropriate perspective.
Supporting Information
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Found at doi:10.1371/journal.pmed.0040079.st001 (162 KB PDF).
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Selection in Epidemiological RisksEditors’ Summary
Background. Medical and scientific researchers use statistical tests to try
to work out whether their observations—for example, seeing a
difference in some characteristic between two groups of people—might
have occurred as a result of chance alone. Statistical tests cannot
determine this for sure, rather they can only give a probability that the
observations would have arisen by chance. When researchers have many
different hypotheses, and carry out many statistical tests on the same set
of data, they run the risk of concluding that there are real differences
where in fact there are none. At the same time, it has long been known
that scientific and medical researchers tend to pick out the findings on
which to report in their papers. Findings that are more interesting,
impressive, or statistically significant are more likely to be published. This
is termed ‘‘publication bias’’ or ‘‘selective reporting bias.’’ Therefore,
some people are concerned that the published scientific literature might
contain many false-positive findings, i.e., findings that are not true but
are simply the result of chance variation in the data. This would have a
serious impact on the accuracy of the published scientific literature and
would tend to overestimate the strength and direction of relationships
being studied.
Why Was This Study Done? Selective reporting bias has already been
studied in detail in the area of randomized trials (studies where
participants are randomly allocated to receive an intervention, e.g., a
new drug, versus an alternative intervention or ‘‘comparator,’’ in order to
understand the benefits or safety of the new intervention). These studies
have shown that very many of the findings of trials are never published,
and that statistically significant findings are more likely to be included in
published papers than nonsignificant findings. However, much medical
research is carried out that does not use randomized trial methods,
either because that method is not useful to answer the question at hand
or is unethical. Epidemiological research is often concerned with looking
at links between risk factors and the development of disease, and this
type of research would generally use observation rather than experiment
to uncover connections. The researchers here were concerned that
selective reporting bias might be just as much of a problem in
epidemiological research as in randomized trials research, and wanted to
study this specifically.
What Did the Researchers Do and Find? In this investigation, searches
were carried out of PubMed, a database of biomedical research studies,
to extract epidemiological studies that were published between January
2004 and October 2005. The researchers wanted to specifically look at
studies reporting the effect of continuous risk factors and their effect on
health or disease outcomes (a continuous risk factor is something like
age or glucose concentration in the blood, is a number, and can have
any value on a sliding scale). Three hundred and eighty-nine original
research studies were found, and the researchers pulled out from the
abstracts and full text of these papers the relative risks that were
reported along with the results of statistical tests for them. (Relative risk
is the chance of getting an outcome, say disease, in one group as
compared to another group.) The researchers found that nearly 90% of
these studies had one or more statistically significant risks reported in
the abstract, but only 43% reported one or more risks that were not
statistically significant. When looking at all of the findings reported
anywhere in the full text for 50 of these studies, the researchers saw that
papers overall reported more statistically significant risks than non-
significant risks. Finally, it seemed that in the set of papers studied here,
the way in which statistical analyses were done produced a bias towards
more extreme findings: for datasets showing small relative risks, papers
were more likely to report a comparison between extreme subsets of the
data so as to report larger relative risks.
What Do These Findings Mean? These findings suggest that there is a
tendency among epidemiology researchers to highlight statistically
significant findings and to avoid highlighting nonsignificant findings in
their research papers. This behavior may be a problem, because many of
these significant findings could in future turn out to be ‘‘false positives.’’
At present, registers exist for researchers to describe ongoing clinical
trials, and to set out the outcomes that they plan to analyze for those
trials. These registers will go some way towards addressing some of the
problems described here, but only for clinical trials research. Registers do
not yet exist for epidemiological studies, and therefore it is important
that researchers and readers are aware of and cautious about the
problem of selective reporting in epidemiological research.
Additional Information. Please access these Web sites via the online
version of this summary at http://dx.doi.org/10.1371/journal.pmed.
0040079.
  Wikipedia entry on publication bias (note: Wikipedia is an internet
encyclopedia that anyone can edit)
  The International Committee of Medical Journal Editors gives guide-
lines for submitting manuscripts to its member journals, and includes
comments about registration of ongoing studies and the obligation to
publish negative studies
  ClinicalTrials.gov and the ISRCTN register are two registries of ongoing
clinical trials
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